Monoclonal Antibody Development
BioGenes has a proven track record with more than 500 monoclonal antibodies (mAb) developed and produced for use as diagnostic reagents and in ELISA kits, amongst others. In particular, customers value the personal service provided by our dedicated team as well as the fact that each and every monoclonal antibody project is truly customized.
What does this mean?
Each project is conducted in close cooperation with the customer and starts with a detailed project discussion to encompass the:
Aim of the project
Selection of mice and immunization schedule for monoclonal antibody development
Screening system and optional additional screenings to include or exclude cross-reactivities
Selection criteria and conditions
Further tests at the customer's lab, if required
Throughout the project, all results are provided to the customer. Thus, they are able to check the progress, modify, repeat or stop work packages, depending on the results and customer's specific requests.
After finalization of the project, all intellectual property and materials generated by BioGenes (clones, cryo cultures, antibodies etc.) are owned solely by the customer. BioGenes also offers long-term storage solutions for convenient maintenance of generated monoclonal antibody products if necessary (see below).
For protein antigens
For peptide antigens
Following monoclonal antibody development we offer several additional services:
Production of antibodies
Antibody pair search
Modification of antibodies
Determination of antibody affinity constant by ELISA
Long-term storage and maintenance of hybridomas